Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats.

about

Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway.

P2860

Q55534932-33937E7E-4B08-4C98-B0D2-299F028A8175

P2860

Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats.

Item

http://www.wikidata.org/entity/Q53121069

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@en

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@nl

type

Item

label

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@en

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@nl

prefLabel

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@en

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@nl

P1476

Comparative pharmacokinetics o ...... tinal motility disorders rats.

@en

P2093

Binjie Wang

http://www.w3.org/2001/XMLSchema#string

Longshan Zhao

http://www.w3.org/2001/XMLSchema#string

Meiyu Zhang

http://www.w3.org/2001/XMLSchema#string

Ping Guo

http://www.w3.org/2001/XMLSchema#string

Shixiao Wang

http://www.w3.org/2001/XMLSchema#string

Shujuan Li

http://www.w3.org/2001/XMLSchema#string

Xiaohui Chen

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Insight into the pharmacokinetic behavior of tanshinone IIA in the treatment of Crohn's disease: comparative data for tanshinone IIA and its two glucuronidated metabolites in normal and recurrent colitis models after oral administration.

Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.

Epidemiology, mechanisms, and management of diabetic gastroparesis.

Mosapride in gastrointestinal disorders.

Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract.

Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice

Comparative pharmacokinetic study of the main components of cortex fraxini after oral administration in normal and hyperuricemic rats.

New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.

Targeting ion channels for the treatment of gastrointestinal motility disorders

Physiologically based pharmacokinetic model of docetaxel and interspecies scaling: comparison of simple injection with folate receptor-targeting amphiphilic copolymer-modified liposomes.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498254.2017.1365974

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28786731

http://www.w3.org/2001/XMLSchema#string

Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats.

about

P2860

P2860

Comparative pharmacokinetics of (S)-MP3950, a novel 5-HT4 receptor agonist, in normal and atropine-induced gastrointestinal motility disorders rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P577

P698